Cha is our partner in the blood cell program and has a majority interest in it: Leading Korean Biotech Company & Advanced Cell Technology Form JV December 1, 2008 http://www.advancedcell.com/news-and-media/press-releases/leading-korean-biotech-company-and-advanced-cell-technology-form-jv/ The JV, located at ACTC facilities was initially named Allied Cell Technology but was quickly renamed: Joint Venture Between CHA Biotech and Advanced Cell Technology to be called Stem Cell & Regenerative Medicine International December 30, 2008 http://www.advancedcell.com/news-and-media/press-releases/joint-venture-between-cha-biotech-and-advanced-cell-technology-to-be-called-stem-cell-and-regenerativ/